About this trial
There is very limited data of HDV in Thailand. As both HDV and HIV can accelerate the HBV course and increased the risk of death, particularly, among those with low CD4 cells/count, therefore, HDV burden in this special population is unmet need. Therefore, this study plans to perform a nationwide survey of the prevalence and predictor of HDV among people uses drugs (PWID) with and without HIV, HBV/HIV (MSM vs non MSM), HBV related cirrhosis. Findinds from this study will provide the scientific community to understand how important HDV is among HBV patients, this could be used to develop strategies for HDV screening and treatment
Eligibility criteria
Qualifiers
Male or female, aged 18 years and older
Provide signed and dated informed consent form.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
The HIV Netherlands Australia Thailand Research Collaboration
Lead sponsor
King Chulalongkorn Memorial Hospital
Collaborator
Thai Red Cross AIDS Research Centre
Collaborator
Siriraj Hospital
Collaborator
Taksin Hospital
Collaborator
Gilead Sciences
Collaborator